BREAKING NEWS: GLAXO TAKES THE LEAD IN THE FIGHT FOR VACCINE PROFITS WITH BLOCKBUSTER SALES

 In News
18 Shares

BREAKING NEWS: GLAXO TAKES THE LEAD IN THE FIGHT FOR VACCINE PROFITS WITH BLOCKBUSTER SALES

GlaxoSmithKline took in $7+ BILLION in 2017 in vaccine sales, beating out Merck as top-dog in the war for vaccine PROFITS.

Glaxo’s vaccine division grew at 6% in 2017, DOUBLE the growth of their pharmaceutical division. Ever heard vaccines were not profitable? That’s FALSE!

Vaccines are the next blockbuster drugs for pharmaceutical companies.

Forecasters expect vaccine profits to skyrocket, with STRONG growth predicted for the next decade. The number of vaccines on the childhood and adult schedule will only increase — as will profits at the expense of YOUR health.

There are nearly 300 vaccines in development and the US vaccine industry is completely protected from lawsuits by the federal government, even when people are seriously injured or killed by a vaccine. ALL PROFIT, WITH NO RISK FOR PHARMA.

VACCINES ARE THE ONLY PRODUCT PROTECTED FROM LAWSUITS. If they are so safe, why do they need protection?

Think vaccines are for health?!! Think again… $$$

GlaxoSmithKline tops its peers with $7.16B in 2017 vaccine sales

18 Shares
Recent Posts
Comments
  • Steve Mazur
    Reply

    $26.71B dollars taken in, not profit, by the top 4 companies. In comparison, all 80,000 chiropractors in the US combined took in, not profited, around $8B.

Leave a Comment

Contact Us

Questions about vaccines?? Want good resources? Need support?! Send us an email and we'll get back to you.

Not readable? Change text. captcha txt
0
Close
X